Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Total article views   HTML views PDF downloads Totals
13,863 Dovepress* 12,751+ 1,591 14,342
PubMed Central* 1,112 391 1,503
Totals 13,863 1,982 15,845
*Since 27 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar